We’re excited to offer our clients access to Software Mind’s comprehensive offer, while enhancing Software Mind’s ability to work side-by-side with organizations in the US.” According to Grzegorz ...
The company is focused on investigating Psilocibin, Ketamine and Ibogaine compounds to be used in the treatment of physical and psychological pain and related mental health illnesses These three ...
Polish-listed Ailleron has signed a letter of intent with U.S. private equity firm Tailwind Capital regarding the potential sale of Software Mind, a software house in which Ailleron holds nearly 50% ...
The last time I wrote about Mind Medicine (MindMed) Inc. (MNMD) was when it was gearing up to report results from a phase 2b study known as MMED008, which was using its drug MM120 for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results